CA996936A - 1,4-dihydro-1-substituted-4-oxo-3-quinoline-carboxylic acid derivative - Google Patents

1,4-dihydro-1-substituted-4-oxo-3-quinoline-carboxylic acid derivative

Info

Publication number
CA996936A
CA996936A CA176,285A CA176285A CA996936A CA 996936 A CA996936 A CA 996936A CA 176285 A CA176285 A CA 176285A CA 996936 A CA996936 A CA 996936A
Authority
CA
Canada
Prior art keywords
quinoline
dihydro
oxo
substituted
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA176,285A
Other languages
English (en)
Other versions
CA176285S (en
Inventor
Hideo Agui
Toshiaki Komatsu
Akio Izawa
Takenari Nakagome
Mitsuo Nakashita
Iwao Nakatsuka
Yasuko Eda
Toru Mitani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Application granted granted Critical
Publication of CA996936A publication Critical patent/CA996936A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
CA176,285A 1972-07-14 1973-07-12 1,4-dihydro-1-substituted-4-oxo-3-quinoline-carboxylic acid derivative Expired CA996936A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7113272A JPS5443000B2 (de) 1972-07-14 1972-07-14

Publications (1)

Publication Number Publication Date
CA996936A true CA996936A (en) 1976-09-14

Family

ID=13451729

Family Applications (1)

Application Number Title Priority Date Filing Date
CA176,285A Expired CA996936A (en) 1972-07-14 1973-07-12 1,4-dihydro-1-substituted-4-oxo-3-quinoline-carboxylic acid derivative

Country Status (10)

Country Link
JP (1) JPS5443000B2 (de)
BE (1) BE802345A (de)
CA (1) CA996936A (de)
CH (1) CH582152A5 (de)
DE (1) DE2335760A1 (de)
FR (1) FR2192836B1 (de)
GB (1) GB1399184A (de)
HU (1) HU167381B (de)
NL (1) NL7309794A (de)
SE (1) SE386677B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5087827U (de) * 1973-12-13 1975-07-25
JPS50117909A (de) * 1974-02-27 1975-09-16
JPS50117908A (de) * 1974-02-27 1975-09-16
JPS55150548U (de) * 1979-04-17 1980-10-30

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2030899A1 (de) * 1970-06-18 1971-12-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen Chinolincarbonsäurederivate
FR2101004B2 (de) * 1970-08-05 1974-02-01 Bellon Labor Sa Roger
FR2100883A1 (en) * 1971-07-09 1972-03-24 Sumitomo Chemical Co 1,4-Dihydro-1-substd-4-oxo-3-quinoline carboxylic acids and esters - having antibacterial activity
DE2134451C3 (de) * 1971-07-09 1982-02-11 Sumitomo Chemical Co., Ltd., Osaka 1,4-Dihydro-1methoxy-6,7-methylendioxy-4-oxo-3-chinolincarbonsäure und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
JPS4930369A (de) 1974-03-18
SE386677B (sv) 1976-08-16
FR2192836B1 (de) 1976-10-22
DE2335760A1 (de) 1974-01-24
BE802345A (fr) 1973-11-05
NL7309794A (de) 1974-01-16
HU167381B (de) 1975-09-27
CH582152A5 (de) 1976-11-30
GB1399184A (en) 1975-06-25
JPS5443000B2 (de) 1979-12-17
FR2192836A1 (de) 1974-02-15

Similar Documents

Publication Publication Date Title
CA999589A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
AU469779B2 (en) Phenylalkenoic acid derivatives
CA1012534A (en) 2,6-diaminonebularine derivatives
CA999588A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA1004677A (en) 3,4-substituted-5-sulfamoyl benzoic acid derivatives
CA1010036A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA996936A (en) 1,4-dihydro-1-substituted-4-oxo-3-quinoline-carboxylic acid derivative
CA993452A (en) 2,6-dihalo-4-cyanophenoxy-acetonitriles
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
CA1020953A (en) 2,2,3-endo-trimethyl-7-anti-amino-norbornanes
CA1010880A (en) 3,5-dialkyl-4-hydroxybenzoic acid esters
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
AU474523B2 (en) Substituted 9,10-dihydroanthracenes
CA999595A (en) 3,5-dialkyl-4-hydroxybenzyl-oxiranes and -thiiranes
AU472337B2 (en) 11, 12-secoprostaglandins
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
AU473140B2 (en) New sulfamylbenzoic acid derivatives
CA942311A (en) 1,4-dihydro-1-substituted-4-oxo-3-quinoline-carboxylic acid derivative
CA990280A (en) 5,6-trans-25-hydroxycholecalciferol
CA987669A (en) 10,11-anhydroerythromycins
CA986936A (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
CA1032162A (en) Phthalazine-1-acetic acid derivatives
AU471234B2 (en) New sulfamylbenzoic acid derivatives
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
CA905961A (en) Certain 2-hydroxymethyl-3-carboxylic acid amidoquinoxaline-di-n-oxides (1,4)